Microenvironment on Demand: A breakthrough technology for personalized cell therapy discoveries

C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

NCI estimates that cancer will be the leading cause of death in 2030, worldwide.  Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durable responses in a few patients while many patients experience life-threatening side-effects. So, there is a critical need to identify cost-effective therapies to treat cancer with minimal to no side-effects.  Deep mapping of cancer antigens and their cognate immune cells is one approach that has the potential for more universal/targeted treatment. However, no methods exist that can identify cancer antigens and their cognate immune cells functionally and link phenotypic readouts to antigen and immune cell DNA sequences, 100k-1M cell combinations at a time. We will show proof-of-concept for the MOD platform that integrates three technologies after fluorescently-labeled single-cells are encapsulated in droplets – droplet-based cell-sorting and merging, single-cell-based interferon-gamma assays and selective sequencing of T-cell receptor variable regions based on interferon-gamma signals.

Learning Objectives:

1. Importance of linked neoantigen/TCR sequence information

2. Microenvironment on demand technology’s role in screening for adoptive cancer cell therapies (T-cell and CAR-Ts)


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
JUL 13, 2021 11:00 AM PDT
C.E. CREDITS
JUL 13, 2021 11:00 AM PDT
Date: July 13, 2021 Time: 11:00am (PDT), 1:00pm (EDT) 1 R&D, Cell Culture & Fermentation Sciences, Bio Pharmaceutical Development, AstraZeneca, Gaithersburg, USA, 2 R&D, ADPE, Ce...
Loading Comments...
Show Resources